Age-related
Macular Degeneration (AMD) is
a degenerative disorder that slowly robs people of their central
vision. In it's advanced stages, people with AMD lose the ability
to see straight ahead and can no longer drive, read, recognize
faces, watch television, or do any fine work. For those suffering
from AMD, this loss of independence can be devastating. Unfortunately,today
there are no good treatments fo this incurable disorder. AMD
currently affects 13 million people in the United States alone,
and is the leading cause of blindness in people over age 55.
This has become a growing public health concern, as over 200,000
Americans each year lose their vision to AMD. As the "baby
boom" population ages, these numbers will increase dramatically.
Diabetic Retinopathy is
a blinding eye disease that affects patients suffering from diabetes.
It is a particularly devastating condition as it generally attacks
both eyes, complicates an already difficult medical life. With
regular examinations and treatment through laser therapy and
surgery, loss of vision can often be slowed or minimized. Yet,
despite these treatments over three million people currently
have diabetic retinopathy. This disease remains the leading cause
of vision loss in Americans aged 25-55. Only through research
will we develop new ways to prevent and treat retinal diseases
and save precious sight. In recent years, thanks to the help
and support of many people, doctors at the Massachusetts Eye
and Ear Infirmary and elsewhere have successfully developed a
new treatment - photodynamic therapy - to isolate and safely
destory unwanted blood vessels in the retina. A second treatment
that blocks retinal blood vessel growth is currently in clinical
trials and will soon be available as another option for treating
macular degeneration, and eventually, diabetic retinopathy.
There is still a great deal of research to be donw to refine and improve
these treatments, and other avenues of research, including geneticcs,
to be further explored. Your support of the Retina Research Institute
at the Massachusetts Eye and Ear Infirmary will help to accelerate these
sight-saving research efforts.
|